Radojcic, Vedran http://orcid.org/0000-0002-9699-1157
Luznik, Leo
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1K08HL145116-01A1)
Article History
Received: 15 October 2020
Revised: 22 October 2020
Accepted: 30 October 2020
First Online: 20 November 2020
Compliance with ethical standards
:
: VR—Consultant: Regeneron Pharmaceuticals. LL—Consultant/Advisory Board: AbbVie, Precision Biosciences, Talaris; Research Support: Genentech and Merck; Patent Holder: WindMiL Therapeutics.